We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$224M
AUM Growth
-$7.34M
Cap. Flow
-$6.76M
Cap. Flow %
-3.02%
Top 10 Hldgs %
32.72%
Holding
117
New
10
Increased
8
Reduced
37
Closed
12

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$6.31M
2
ADBE icon
Adobe
ADBE
+$3.36M
3
SYK icon
Stryker
SYK
+$3.14M
4
JPM icon
JPMorgan Chase
JPM
+$2.44M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.91M

Sector Composition

Rank Sector Weight
1 Communication Services 25.3%
2 Healthcare 20.7%
3 Energy 14.37%
4 Industrials 12.84%
5 Technology 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZG icon
101
Zillow
ZG
$8.23B
-8,000
Closed -$208K
TVRD
102
Tvardi Therapeutics
TVRD
$24.3M
-6,857
Closed -$4.16M
AGTC
103
DELISTED
Applied Genetic Technologies Corporation
AGTC
-128,377
Closed -$2.62M
NGLS
104
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
-37,395
Closed -$618K

Similar funds

Private Capital Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Private Capital Advisors held 117 positions worth $224M, down 3.2% from $232M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Private Capital Advisors withdrew a net $6.76M in Q1 2016, closing 12 positions and reducing 37 holdings. Its most notable exit was Tvardi Therapeutics, an estimated $4.16M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Private Capital Advisors opened a new position in Raytheon Company worth $6.28M.

  • Private Capital Advisors's largest Q1 2016 buy was Raytheon Company: 51,240 shares worth $6.28M.
  • Private Capital Advisors added most to Alphabet (Google) Class A in Q1 2016, an estimated $1.91M increase.
  • Private Capital Advisors's biggest Q1 2016 reduction was 3M, cutting an estimated $4.07M.
  • Private Capital Advisors fully exited Tvardi Therapeutics in Q1 2016, selling an estimated $4.16M.
  • Private Capital Advisors's ten largest holdings make up 33% of its $224M portfolio in Q1 2016.
  • Private Capital Advisors opened 10 new positions and closed 12 in Q1 2016.
  • Private Capital Advisors's portfolio value fell 3.2% quarter-over-quarter to $224M.

Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.